Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTTICH Pilot Study
NCT02260908Unknown
- Sponsor
- McMaster University
- Start
- Oct 2014
- Primary completion
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of enoxaparin in venous thromboembolism (VTE) (2 arms), sponsored by McMaster University. Primary endpoint: Proximal lower limb deep vein thrombosis at 60 days. Status: unknown.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02260908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02260908.